FACTORS AFFECTING WARFARIN REQUIREMENTS - PROSPECTIVE POPULATION STUDY

被引:80
|
作者
ROUTLEDGE, PA
CHAPMAN, PH
DAVIES, DM
RAWLINS, MD
机构
[1] UNIV NEWCASTLE UPON TYNE, WOLFSON UNIT CLIN PHARMACOL, DEPT PHARMACOL SCI, NEWCASTLE UPON TYNE NE1 7RU, TYNE & WEAR, ENGLAND
[2] SHOTLEY BRIDGE GEN HOSP, DEPT CLIN PHARMACOL, DURHAM, ENGLAND
关键词
age; anticoagulation; sex; warfarin; weight;
D O I
10.1007/BF00558434
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
In 228 ambulatory patients receiving treatment with warfarin, there was a progressive decline in the dose required to produce an equivalent degree of anticoagulant control with increasing age from the third decade onwards. However, the relationship between age and dose was significant only in patients receiving warfarin after episodes of venous thromboembolism or because of coronary artery disease. Patient weight was also related to warfarin requirements, although it was less important a determinant than age. © 1979 Springer-Verlag.
引用
收藏
页码:319 / 322
页数:4
相关论文
共 50 条
  • [31] Natal factors affecting developmental defects of enamel in preterm infants: a prospective cohort study
    Park, Shang-yon
    Jeong, Su Jin
    Han, Jung Ho
    Shin, Jeong Eun
    Lee, Jae-Ho
    Kang, Chung-Min
    SCIENTIFIC REPORTS, 2024, 14 (01)
  • [32] Factors Affecting Cancer Mortality in Young Adults: Findings from a Prospective Cohort Study
    Le, Ngoan T.
    Pham, Yen T. -H.
    Le, Linh T.
    Dao, Hang V.
    Koriyama, Chihaya
    Ha, Toan H.
    Lichtveld, Maureen
    Kuchipudi, Suresh V.
    Huynh, Nhi Y. -N.
    Nguyen, Dai D.
    Luu, Hung N.
    CANCERS, 2024, 16 (22)
  • [33] Risk factors for nonadherence to warfarin: results from the IN-RANGE study
    Platt, Alec B.
    Localio, A. Russell
    Brensinger, Colleen M.
    Cruess, Dean G.
    Christie, Jason D.
    Gross, Robert
    Parker, Catherine S.
    Price, Maureen
    Metlay, Joshua P.
    Cohen, Abigail
    Newcomb, Craig W.
    Strom, Brian L.
    Laskin, Mitchell S.
    Kimmel, Stephen E.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2008, 17 (09) : 853 - 860
  • [34] A Prospective Study on the Use of Warfarin in the United Arab Emirates
    Shehab, Abdulla
    Elnour, Asim
    Abdulle, Abdishakur
    Souid, Abdul-Kader
    OPEN CARDIOVASCULAR MEDICINE JOURNAL, 2012, 6 : 72 - 75
  • [35] A population survey of early factors associated with permanent tooth emergence: findings from a prospective cohort study
    Wong, Hai Ming
    Peng, Si-Min
    Wen, Yi Feng
    McGrath, Colman P. J.
    COMMUNITY DENTISTRY AND ORAL EPIDEMIOLOGY, 2016, 44 (05) : 467 - 475
  • [36] Pharmacogenetics of Warfarin in a Diverse Patient Population
    Mak, May
    Lam, Carol
    Pineda, Sandra J.
    Lou, Mimi
    Xu, Lilia Yang
    Meeks, Christopher
    Lin, Cindy
    Stone, Roslynn
    Rodgers, Kathy
    Mitani, Gladys
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS, 2019, 24 (06) : 521 - 533
  • [37] Factors Affecting the Outcomes of Patients with Malignant Rhabdoid Tumors: A Population-Based Study
    Cai, Wen
    Liu, Xue
    Ge, Weiting
    Wu, Dehao
    Xu, Junxi
    Bai, Rui
    Hue, Hanguang
    INTERNATIONAL JOURNAL OF MEDICAL SCIENCES, 2021, 18 (04): : 911 - 920
  • [38] Factors affecting target INR levels in homebound and ambulatory patients who use warfarin
    Tuncer, Ozge
    Sakalli, Ayca Asma
    Gursoy, Mustafa Ozan
    JOURNAL OF THE PAKISTAN MEDICAL ASSOCIATION, 2024, 74 (12) : 2132 - 2138
  • [39] THE INFLUENCE OF AGE, LIVER SIZE AND ENANTIOMER CONCENTRATIONS ON WARFARIN REQUIREMENTS
    WYNNE, H
    COPE, L
    KELLY, P
    WHITTINGHAM, T
    EDWARDS, C
    KAMALI, F
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1995, 40 (03) : 203 - 207
  • [40] Evaluation of Pharmacogenetic Algorithm for Warfarin Dose Requirements in Japanese Patients
    Takeuchi, Fumihiko
    Kashida, Mitsuo
    Okazaki, Osamu
    Tanaka, Yuriko
    Fukuda, Shoji
    Kashima, Toshitaka
    Hosaka, Shigeru
    Hiroe, Michiaki
    Kimura, Sosuke
    Kato, Norihiro
    CIRCULATION JOURNAL, 2010, 74 (05) : 977 - 982